The European Medicines Agency says that it has been formally notified by Schering-Plough that the company is withdrawing a submission to get the green light for Cylatron for melanoma.
Read MoreMannKind Corp has submitted a New Drug Application to regulators in the USA requesting approval of Afresa, its inhaled insulin drug.
Read MoreDays after having a bid accepted to get full control of Genentech, Roche has hit the acquisition trail again though on a much, much smaller level.
Read MoreArk Therapeutics has posted a reasonable set of financials for 2008 which saw a narrowing of losses but lower revenues as analysts wait for a possible approval of Cerepro, the UK firm’s gene-based therapy for brain cancer.
Read MoreShire says that it has decided to withdraw a submission to regulators in Europe for Daytrana, its patch for attention deficit hyperactivity disorder.
Read More
